Eliem Therapeutics, Inc. Contracts & Agreements
38 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (2)
- Human Resources (16)
- Intellectual Property (2)
- Mergers & Acquisitions (2)
- Uncategorized (7)
- Amendment to Consulting Agreement, dated November 1, 2024, between Registrant and Stephen Thomas (Filed With SEC on November 12, 2024)
- Consulting Agreement, dated June 27, 2024, between the Registrant and Stephen Thomas (Filed With SEC on November 12, 2024)
- Settlement Agreement, dated August 23, 2024, between Eliem Therapeutics, Inc. and Valerie Morisset, Ph.D (Filed With SEC on August 27, 2024)
- Offer Letter, dated July 31, 2024, between Eliem Therapeutics, Inc. and Brett Kaplan, M.D (Filed With SEC on August 26, 2024)
- Cell Line Development, Manufacturing Services and License Agreement, effective as of February 9, 2021, by and between ValenzaBio, Inc. and ProBioGen, Inc (Filed With SEC on June 27, 2024)
- Amended and Restated License Agreement, dated as of January 11, 2024, by and between Tenet Medicines, Inc. and Cancer Research Technology Limited (Filed With SEC on June 27, 2024)
- Asset Purchase Agreement, dated as of January 11, 2024, by and between Tenet Medicines, Inc., Acelyrin, Inc. and WH2, LLC (Filed With SEC on June 27, 2024)
- Offer Letter, dated June 12, 2024, between Eliem and Aoife Brennan (Filed With SEC on June 12, 2024)
- Senior Secured Promissory Note, dated as of May 14, 2024, between Eliem Therapeutics, Inc. and Tenet Medicines, Inc (Filed With SEC on May 15, 2024)
- Registration Rights Agreement, dated April 10, 2024, by and among Eliem Therapeutics, Inc. and the persons party thereto (Filed With SEC on April 11, 2024)
- Securities Purchase Agreement, dated April 10, 2024, by and among Eliem Therapeutics, Inc. and the persons party thereto (Filed With SEC on April 11, 2024)
- Form of Lock-Up Agreement (Filed With SEC on April 11, 2024)
- Form of Tenet Support and Joinder Agreement (Filed With SEC on April 11, 2024)
- Form of Company Support Agreement (Filed With SEC on April 11, 2024)
- Agreement and Plan of Merger and Reorganization, dated as of April 10, 2024, by and among Eliem Therapeutics, Inc., Tango Merger Sub, Inc., Tenet Medicines, Inc. and, solely in... (Filed With SEC on April 11, 2024)
- Separation and Consulting Agreement, dated February 13, 2023, by and between Eliem Therapeutics, Inc. and James B. Bucher (Filed With SEC on March 28, 2024)
- Executive Employment Agreement by and between the Eliem Therapeutics, Inc. and James B. Bucher, effective October 1, 2020 (Filed With SEC on March 28, 2024)
- Separation and Consulting Agreement, dated February 13, 2023, by and between Eliem Therapeutics, Inc. and Robert Azelby (Filed With SEC on February 14, 2023)
- Separation and Consulting Agreement, dated February 13, 2023, by and between Eliem Therapeutics, Inc. and Erin Lavelle (Filed With SEC on February 14, 2023)
- Description of Securities (Filed With SEC on March 7, 2022)
- Forms of Option Agreement and Notice of Exercise under the 2019 Equity Incentive Plan (Filed With SEC on August 2, 2021)
- Form of Underwriting Agreement (Filed With SEC on August 2, 2021)
- Form of common stock certificate of the Registrant (Filed With SEC on August 2, 2021)
- 2021 Equity Incentive Plan (Filed With SEC on August 2, 2021)
- Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2021 Equity Incentive Plan (Filed With SEC on August 2, 2021)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Equity Incentive Plan (Filed With SEC on August 2, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on August 2, 2021)
- Form of Indemnification Agreement, by and between the Registrant and each of its directors and executive officers (Filed With SEC on August 2, 2021)
- Executive Employment Agreement by and between the Registrant and Bob Azelby, effective October 1, 2021, as amended (Filed With SEC on August 2, 2021)
- Executive Employment Agreement by and between the Registrant and Erin M. Lavelle, effective October 1, 2021, as amended (Filed With SEC on August 2, 2021)
- Unit Transfer Agreement, dated February 4, 2019, by and between the Registrant and the Members of NeoKera, LLC (Filed With SEC on July 16, 2021)
- Executive Employment Agreement by and between Eliem Therapeutics (UK) Ltd. and Valerie Morisset, Ph.D., effective January 1, 2021 (Filed With SEC on July 16, 2021)
- Executive Employment Agreement by and between the Registrant and Erin M. Lavelle, effective October 1, 2021 (Filed With SEC on July 16, 2021)
- Executive Employment Agreement by and between the Registrant and Bob Azelby, effective October 1, 2021 (Filed With SEC on July 16, 2021)
- 2019 Equity Incentive Plan, as amended (Filed With SEC on July 16, 2021)
- Amended and Restated Investor Rights Agreement, dated May 21, 2021, by and among the Registrant and the investors listed on Schedule A thereto (Filed With SEC on July 16, 2021)
- Agreement and Plan of Merger and Reorganization, dated October 15, 2020, by and among the Registrant, Athena Merger Sub Inc., Athenen Therapeutics, Inc., AI ETI LLC, as Eliem... (Filed With SEC on July 16, 2021)
- Asset Contribution Agreement, dated February 4, 2019, by and between the Registrant and Carnot, LLC (Filed With SEC on July 16, 2021)
